# A First-in-Human Study With XAB05 in Healthy Subjects

> **NCT05307406** · PHASE1 · COMPLETED · sponsor: **Xenothera SAS** · enrollment: 25 (actual)

## Conditions studied

- Infection, Bacterial

## Interventions

- **BIOLOGICAL:** Experimental

## Key facts

- **NCT ID:** NCT05307406
- **Lead sponsor:** Xenothera SAS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-24
- **Primary completion:** 2022-05-19
- **Final completion:** 2022-05-19
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05307406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05307406, "A First-in-Human Study With XAB05 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05307406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*